|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Aug 28, 2024 |
Title |
SMARCA4 controls state plasticity in small cell lung cancer through regulation of neuroendocrine transcription factors and REST splicing [RNA-seq] |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Small Cell Lung Cancer (SCLC) can be classified into transcriptional subtypes with distinct degrees of neuroendocrine (NE) differentiation. Recent evidence supports plasticity among subtypes with a bias toward adoption of low-NE states during disease progression or upon acquired chemotherapy resistance. Here, we identify a role for SMARCA4, the catalytic subunit of the SWI/SNF complex, as a regulator of subtype shift in SCLC. SMARCA4 binds to gene loci encoding NE-lineage transcription factors ASCL1 and NEUROD1 and alters chromatin accessibility, suppressing NE programs. In parallel, SMARCA4 also controls REST, a known suppressor of the NE phenotype, by regulating SRRM4-dependent REST splicing. The SMARCA2/4 inhibitor FHD-286 induces loss of NE features and drives ERBB pathway activation in SCLC, rendering SCLC tumors sensitive to afatinib. This study nominates SMARCA4 as a key regulator of the NE state plasticity and defines a novel therapeutic strategy for SCLC.
|
|
|
Overall design |
To study the role of SMARCA4/2 in regulating the neuroendocrine phenotype in SCLC, we pharmacologically inhibited this target using FHD-286 and performed gene expression profiling analysis by RNAseq. We treated H146 and H82 cells for 14 days with 100nM of FHD-286. Comparative gene expression profiling of RNAseq data for H82 and H146 treated vs untreated cells.
|
|
|
Contributor(s) |
Redin E, Zhan YA, Rudin CM |
Citation(s) |
39080761 |
|
Submission date |
Feb 22, 2024 |
Last update date |
Aug 28, 2024 |
Contact name |
Yingqian Ada Zhan |
E-mail(s) |
zhany@mskcc.org
|
Organization name |
MSKCC
|
Department |
EPIGENETICS RESEARCH CENTER
|
Street address |
430 East 67th Street
|
City |
New York |
State/province |
New York |
ZIP/Postal code |
10065 |
Country |
USA |
|
|
Platforms (1) |
GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
Samples (13)
|
GSM8094137 |
H146 cells, treated n1 (RNA-seq) |
GSM8094138 |
H146 cells, treated n2 (RNA-seq) |
GSM8094139 |
H146 cells, treated n3 (RNA-seq) |
GSM8094140 |
H146 cells, treated n4 (RNA-seq) |
GSM8094141 |
H82 cells, untreated n1 (RNA-seq) |
GSM8094142 |
H82 cells, untreated n2 (RNA-seq) |
GSM8094143 |
H82 cells, untreated n3 (RNA-seq) |
GSM8094144 |
H82 cells, treated n1 (RNA-seq) |
GSM8094145 |
H82 cells, treated n2 (RNA-seq) |
GSM8094146 |
H82 cells, treated n3 (RNA-seq) |
|
Relations |
BioProject |
PRJNA1079237 |
Supplementary file |
Size |
Download |
File type/resource |
GSE256347_DESeq2_RNAseq_hg38_TPMs_H146.txt.gz |
1.4 Mb |
(ftp)(http) |
TXT |
GSE256347_DESeq2_RNAseq_hg38_TPMs_H82.txt.gz |
1.2 Mb |
(ftp)(http) |
TXT |
SRA Run Selector |
Raw data are available in SRA |
|
|
|
|
|